The ultrasound probe will be placed at the head of the baby and through an open fontanelle, cerebral blood flow can be measured continuously. The probe is smaller than one Norwegian Krone. NeoDoppler will not disturb the child, the medical treatment, the nursing or the parents contact with their child.

Premature infants and critically ill neonates are at increased risk of brain injury the first hours and days of life. NeoDoppler can identify variations in cerebral blood flow and interventions, like optimizing ventilator settings or blood pressure, can be done so brain injury can be prevented.

Use of NeoDoppler is user independent and has considerable advantages over conventional ultrasound imaging, which provides only a snapshot of the brain circulation. 

The first clinical study will start in 2017 at the Neonatal Intensive Care Unit at St. Olavs Hospital.

The NeoDoppler ultrasound system has been developed by Professor Hans Torp and the Ultrasound Group at the Department of circulation and medical imaging, NTNU.